I now have all the information needed for a complete, well-illustrated answer. Let me compile it.
Streptokinase - Complete Guide in Easy Words
Part 1: How a Clot Forms (Before Understanding How Streptokinase Works)
Think of a clot like a dam built in a blood vessel after an injury. Here is how it happens step by step:
Step 1 - Blood vessel gets injured
When a vessel wall breaks, it exposes substances underneath (collagen and tissue factor) that were hidden from blood.
Step 2 - Platelets rush in (Primary plug)
Platelets (tiny blood cells) stick to the injured area and clump together. They release chemicals (ADP, serotonin, thromboxane A2) that call more platelets. They also switch on a receptor called GP IIb/IIIa, which grabs fibrinogen (a glue protein) and links platelets together - forming a soft platelet plug.
Step 3 - Coagulation cascade fires (Fibrin net)
The tissue factor triggers a chain reaction (the coagulation cascade) through two pathways - extrinsic and intrinsic. The end result of both is the same: thrombin is made. Thrombin then cuts fibrinogen into fibrin threads. These threads weave a mesh that traps platelets and blood cells.
Step 4 - Clot is stabilized
Factor XIII cross-links the fibrin threads tightly, making the clot strong and firm.
So the final clot = platelets + fibrin mesh + trapped blood cells = a solid plug blocking blood flow.
Part 2: How Streptokinase Breaks the Clot
Streptokinase is a clot-busting drug (thrombolytic/fibrinolytic). It comes from bacteria - beta-hemolytic streptococci.
Key point: Streptokinase is NOT an enzyme itself
It works in a clever indirect way:
Mechanism - Step by Step (Easy)
Step 1 - Streptokinase binds to Plasminogen
In the blood there is a dormant protein called plasminogen (like a sleeping scissors). Streptokinase latches onto plasminogen in a 1:1 ratio, forming a streptokinase-plasminogen complex.
Step 2 - Shape change unlocks the active site
When streptokinase binds, it bends/twists plasminogen into a new shape (conformational change). This reveals a hidden active site - like opening a folded knife.
Step 3 - The complex acts as a factory
This activated streptokinase-plasminogen(now plasmin) complex now attacks OTHER plasminogen molecules in the blood, converting them to plasmin - the actual clot-cutter.
Step 4 - Plasmin digests the fibrin
Plasmin chops up fibrin threads into small pieces called fibrin degradation products (FDPs). The clot dissolves.
The diagram shows: streptokinase (bottom left, dark blue) binds to plasminogen (right side, light blue) → the complex changes shape (top) → this activated complex converts more plasminogen to plasmin.
The Fibrinolytic System - Big Picture
Two natural brakes exist in this system:
- PAI-1 (Plasminogen Activator Inhibitor-1) - blocks plasminogen activators
- α2-antiplasmin - grabs and destroys free plasmin
Streptokinase generates SO MUCH plasmin that it overwhelms α2-antiplasmin, causing a systemic lytic state - meaning fibrin is broken down everywhere in the body, not just at the clot. This is why bleeding is a major risk.
Why Streptokinase is "Non-Specific" (Important Exam Point)
| Feature | Streptokinase | tPA (alteplase) |
|---|
| Works directly on fibrin? | No - no affinity for fibrin | Yes - fibrin-specific |
| Activates circulating plasminogen? | Yes (both free + clot-bound) | Mostly clot-bound |
| Systemic lytic state? | Yes (high bleeding risk) | Less so |
| Enzyme itself? | No (allosteric modifier) | Yes |
Because streptokinase has no affinity for fibrin, it activates plasminogen floating freely in the blood too - not just the plasminogen sitting on the clot. This floods the body with plasmin, breaking down clotting factors everywhere.
Part 3: Safe Dose
| Indication | Dose | Route & Duration |
|---|
| Acute MI (STEMI) | 1.5 million IU (1,500,000 IU) | IV infusion over 60 minutes |
| Pulmonary embolism | 250,000 IU loading over 30 min, then 100,000 IU/hr for 24 hrs | IV infusion |
| Deep vein thrombosis | 250,000 IU loading, then 100,000 IU/hr for 72 hrs | IV infusion |
The standard and most commonly tested dose is 1.5 million IU IV over 1 hour for acute STEMI.
- Textbook of Family Medicine 9e - Table 27-16: "Streptokinase: 1.5 million IU IV, give infusion over 60 min"
Part 4: Important Safety Points / Contraindications
- Allergic reactions / anaphylaxis - streptokinase is a foreign bacterial protein; antibodies from prior streptococcal infection can cause reactions
- Cannot be re-used within 5 years - prior exposure creates antibodies that neutralize it
- Hypotension - give slowly; can cause BP drop
- Major bleeding risk - 20% risk of major hemorrhage; 3-5% risk of hemorrhagic stroke
- Contraindicated in: recent surgery, active bleeding, history of stroke, severe hypertension, pregnancy
Quick Memory Summary
Injury → Platelet plug + Fibrin mesh → CLOT
↑
Thrombin made from coagulation cascade
↑
Streptokinase → binds Plasminogen → conformational change
→ SK-Plasminogen complex → converts more Plasminogen → PLASMIN
↓
Fibrin → FDPs (clot dissolves)
Dose to remember: 1.5 million IU IV over 60 min (for STEMI)
Sources: Harrison's Principles of Internal Medicine 22E, p. 998 | Braunwald's Heart Disease | Lippincott Illustrated Reviews: Pharmacology | Textbook of Family Medicine 9e